» Articles » PMID: 17241879

STAT3 is Required for IL-6-gp130-dependent Activation of Hepcidin in Vivo

Overview
Specialty Gastroenterology
Date 2007 Jan 24
PMID 17241879
Citations 135
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Hepcidin is a peptide hormone that is central to the regulation of iron homeostasis. In response to interleukin 6 (IL-6), hepatocytes produce hepcidin that decreases iron release/transfer from enterocytes and macrophages and causes hypoferremia. To clarify the molecular pathways involved in hepcidin activation by IL-6, we used different mice strains in which the main IL-6/gp130 signaling pathways have been genetically disrupted.

Methods: We generated mice with hepatocyte-specific deletion of the IL-6 signal-transducing gp130 receptor (alfpgp130 (LoxP/LoxP)), with a gp130 receptor lacking the essential region for STAT1 and -3 activation (alfpCre gp130(DeltaSTAT/LoxP)) or mice expressing a gp130 allele lacking the essential tyrosine for RAS-MAPK activation (alfpCregp130(Y757F/LoxP)). We studied gp130-dependent pathways and hepcidin mRNA expression by Western blot, reverse-transcription polymerase chain reaction, and Northern blot in vivo and ex vivo.

Results: IL-6 stimulated phospho STAT3, serum amyloid A (SAA), and suppressor of cytokine signaling 3 (SOCS3) expression in livers of wild-type and alfpCregp130(Y757F/LoxP) mice, whereas this response was blocked in alfpCre gp130(LoxP/LoxP) and alfpCre gp130(DeltaSTAT/LoxP) mice. In wild-type and alfpCregp130(Y757F/LoxP) animals, significantly higher hepcidin mRNA expression was found 3 to 6 hours after IL-6 stimulation. In contrast, no IL-6-dependent regulation of hepcidin mRNA expression was found in alfpgp130 (DeltaSTAT/LoxP) and AlfpCre gp130 (LoxP/LoxP) animals. In primary hepatocytes, higher hepcidin mRNA expression after IL-6 stimulation was only observed when gp130-STAT3-dependent signaling was intact.

Conclusions: We have demonstrated that both in vivo and in vitro STAT3 is the key transcription factor responsible for IL-6 activation of hepcidin gene expression in the liver.

Citing Articles

Iron metabolism in rheumatic diseases.

Givian A, Azizan A, Jamshidi A, Mahmoudi M, Farhadi E J Transl Autoimmun. 2025; 10:100267.

PMID: 39867458 PMC: 11763848. DOI: 10.1016/j.jtauto.2025.100267.


Predictive Value of Serum Hepcidin Levels for the Risk of Incident End-Stage Kidney Disease in Patients with Chronic Kidney Disease: The KNOW-CKD.

Suh S, Oh T, Choi H, Kim C, Bae E, Ma S Kidney Dis (Basel). 2024; 10(6):492-503.

PMID: 39664339 PMC: 11631166. DOI: 10.1159/000542057.


Oxidative Status, Iron Plasma Levels in Venous Thrombosis Patients.

Signorelli S, Barbagallo A, Oliveri Conti G, Fiore M, Cristaldi A, Ferrante M Antioxidants (Basel). 2024; 13(6).

PMID: 38929128 PMC: 11200582. DOI: 10.3390/antiox13060689.


Predicting gene-level sensitivity to JAK-STAT signaling perturbation using a mechanistic-to-machine learning framework.

Cheemalavagu N, Shoger K, Cao Y, Michalides B, Botta S, Faeder J Cell Syst. 2024; 15(1):37-48.e4.

PMID: 38198893 PMC: 10812086. DOI: 10.1016/j.cels.2023.12.006.


Longitudinal changes in iron homeostasis in human experimental and clinical malaria.

Woolley S, Grigg M, Marquart L, Gower J, Piera K, Nair A medRxiv. 2024; .

PMID: 38196596 PMC: 10775340. DOI: 10.1101/2023.12.19.23300265.